PlainRecalls

Alexion Pharmaceuticals, Inc.

Compiled from official public sources by the publisher.

2 recalls on record · Latest: Aug 13, 2014

Subscribe to new Alexion Pharmaceuticals, In… recalls (RSS)

Agency notice ledger

Federal filing book Alexion Pharmaceuticals, In… LIGHT-BOOK · SINGLE-AGENCY

#4,302 of 14,151 · 2 notices · 0.002% archive

  • BOOK 2 notices
  • RANK #4,302 of 14,151
  • SHARE 0.002% archive
  • AGENCY FDA Drug (2)
  • CAT medical devices
  • CATS 2 categories
  • LATEST Aug 13, 2014
  • PHOTO 3M Company

Nearest notice-volume peer: 3M Company (0 notice gap)

Alexion Pharmaceuticals, Inc. accounts for about 0.002% of the 104,423-notice archive on 2 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

How Alexion Pharmaceuticals, In… compares to 14,151 recalling firms

Alexion Pharmaceuticals, Inc. ranks 4,302nd of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Alexion Pharmaceuticals, In… vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

2 4302nd of 14151 higher than 8,037 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-15

Alexion Pharmaceuticals, In… in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Alexion Pharmaceuticals, Inc. holds about 0.002% of archive notices alongside 2 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Critical Aug 13, 2014

Soliris (eculizumab), 300 mg/30 mL (10 mg/mL), 30 mL Single-Use Vial, Rx only, Manufactured by: Alexion Pharmaceuticals, Inc., Cheshire, CT 06410, NDC 25682-001-01, UPC 3 25682-001-01 6.
FDA Drug Critical Feb 5, 2014

Soliris (eculizumab) Concentrated Solution for Intravenous Infusion Only, 300 mg/30 mL (10 mg/mL), 30 mL Single-Use Vial, Rx only, Manufactured by: Alexion Pharmaceuticals, Inc., Cheshire, CT 06410, NDC 25682-001-01, UPC 3 25682-001-01 6.

Alexion Pharmaceuticals, In… is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar medical devices volume

Nearest multi-notice firms that share this firm's dominant product category.

3M Company 2 3M Company/3m Espe Dental Products 2 A.o. Smith Electrical Products Co., of Tipp City, Ohio 2 Abbott Diagnostics Technologies As 2

Frequently Asked Questions

How many federal recall notices name Alexion Pharmaceuticals, In…? ▼
PlainRecalls indexes 2 distinct federal recall events naming Alexion Pharmaceuticals, Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Alexion Pharmaceuticals, In… sit among other recalling firms? ▼
Alexion Pharmaceuticals, Inc. ranks #4,302 of 14,151 by distinct recall-event count among 14,151 firms in this archive (57th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Alexion Pharmaceuticals, In…'s notices? ▼
FDA Drug accounts for 2 of this firm's 2 indexed notices.
What product category dominates Alexion Pharmaceuticals, In…'s filing book? ▼
Filings for Alexion Pharmaceuticals, Inc. span 2 product categories, led by medical devices. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Alexion Pharmaceuticals, Inc.: 2 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Alexion Pharmaceuticals, Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026